RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00059887.xml
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807970
DOI: 10.1055/s-0045-1807970
PUBLIC POLICY, ACCESS, PHARMACOECONOMICS AND HEALTH MANAGEMENT
2081
POSTER PRESENTATION
Cost-effectiveness analysis of the 21 genes platform for guiding treatment decisions in early hormone positive breast cancer: perspective of the Brazilian public health system
Keywords
cost-effectiveness analysis - 21 genes platform - early hormone positive breast cancer - Brazilian public health system - decision-makingPublikationsverlauf
Artikel online veröffentlicht:
06. Mai 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bibliographical Record
Daniel Cubero, Fernando Fonseca, Beatriz Alves, Luiz Vinicius de Alcantaras, Auro del Giglio. Cost-effectiveness analysis of the 21 genes platform for guiding treatment decisions in early hormone positive breast cancer: perspective of the Brazilian public health system. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807970
Daniel Cubero, Fernando Fonseca, Beatriz Alves, Luiz Vinicius de Alcantaras, Auro del Giglio. Cost-effectiveness analysis of the 21 genes platform for guiding treatment decisions in early hormone positive breast cancer: perspective of the Brazilian public health system. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807970